~~<i id='E456B51245'><strike id='E456B51245'><tt id='E456B51245'><pre id='E456B51245'></pre></tt></strike></i>~~

Home» Wikipedia» Wikipedia

Wikipedia

author：explore 2025-10-02 17:05:09 Page View：63284

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Princess Kate attends Wimbledon with Roger Federer: See the photos
Next article： Medicare details structure of new drug price negotiation program

knowledge

In age of alternative facts, a scholarly course on calling out crap

Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

Former New York Mayor de Blasio and wife announce separation, but not divorce

NewYorkCityMayorBilldeBlasioandhiswifeChirlaneMcCrayarriveforaneventonLibertyIsland,May16,2019,inNew

Moonlake's readout produced a cash windfall. Risks remain

MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

Myanmar's Supreme Court hears arguments in 2 appeals by ousted leader Aung San Suu Kyi

FILE-Myanmar'sleaderAungSanSuuKyi,left,attendsthebilateralmeetingwithChinesePresidentXiJinpingatthep